Category 4- Most Innovative Biotech Award

Open to: Biotechs only

This award aims to promote and drive change through the adoption of innovative technologies to develop novel drugs. This company must have exemplified an expansive and agile approach in their drug development. The company will also be evaluated based on how the organization has implemented new processes, technology or applications that create quantifiable and sustainable results in the drug development process.

Companies will be judged on the following criteria:

• Developed a code of conduct/standards for its own organization that target innovative efforts towards developing novel drugs
• Unconventional best practices that demonstrate business progress and successful integration of business functions and resource optimization
• Creative ways of collaboration with external suppliers to jointly develop and strengthen relationships
• Pioneering initiatives with measurable components - Results are evaluated against KPIs

Winner of the Most Innovative Biotech Award at the 2nd Annual BioPharma Asia Industry Excellence Awards:

Innogene Kalbiotech

Rikrik Ilyas, Managing Director, Innogene Kalbiotech, Singapore